Assignee profile:

XWPHARMA LTD.

City:

Grand Cayman

Country:

Cayman Islands

Published Applications:

27

Last publication date:

2024-10-24

Patent Grants:

27

Last grant date:

2026-04-28

Top Inventors for applications by XWPHARMA LTD.

These are the the leading inventors for applications assigned to XWPHARMA LTD.:

Recent patent applications by XWPHARMA LTD.

XWPHARMA LTD. based in Grand Cayman, KY has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-24 ✅ Patent 12,612,357 granted on 2026-04-28
US20240351975A1
Chemistry; metallurgy

METHODS OF SYNTHESIZING 4-VALYLOXYBUTYRIC ACID

#2 | 2024-05-16 ✅ Patent 12,396,956 granted on 2025-08-26
US20240156741A1
Human necessities

MODIFIED RELEASE COMPOSITIONS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#3 | 2023-11-09 ✅ Patent 12,030,834 granted on 2024-07-09
US20230357130A1
Chemistry; metallurgy

Methods of synthesizing 4-valyloxybutyric acid

#4 | 2023-09-28 ✅ Patent 12,234,226 granted on 2025-02-25
US20230303530A1
Chemistry; metallurgy

Compounds as nuclear transport modulators and uses thereof

#5 | 2023-09-14 ✅ Patent 12,396,966 granted on 2025-08-26
US20230285325A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES

#6 | 2023-03-30 ✅ Patent 11,690,811 granted on 2023-07-04
US20230098084A1
Human necessities

Pharmaceutical compositions and oral dosage forms of ketamine derivatives

#7 | 2023-03-02 ✅ Patent 11,944,597 granted on 2024-04-02
US20230067371A1
Human necessities

Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative

#8 | 2022-12-29 ✅ Patent 12,209,060 granted on 2025-01-28
US20220411365A1
Chemistry; metallurgy

Ketamine derivatives and compositions thereof

#9 | 2022-12-01 ✅ Patent 12,172,980 granted on 2024-12-24
US20220380339A1
Chemistry; metallurgy

Compounds as neuronal histamine receptor-3 antagonists and uses thereof

#10 | 2022-10-13 ✅ Patent 11,925,710 granted on 2024-03-12
US20220323365A1
Human necessities

Modified release compositions of a GAMMA-hydroxybutyric acid derivative

#11 | 2022-09-29 ✅ Patent 11,510,892 granted on 2022-11-29
US20220304969A1
Human necessities

Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative

#12 | 2022-09-22 ✅ Patent 11,639,337 granted on 2023-05-02
US20220298127A1
Chemistry; metallurgy

Bicyclic heteroaryl derivatives and preparation and uses thereof

#13 | 2022-07-28 ✅ Patent 11,746,081 granted on 2023-09-05
US20220234994A1
Chemistry; metallurgy

Methods of synthesizing 4-valyloxybutyric acid

#14 | 2022-06-16 ✅ Patent 12,337,066 granted on 2025-06-24
US20220183977A1
Human necessities

CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS

#15 | 2022-04-07 ✅ Patent 11,395,801 granted on 2022-07-26
US20220105044A1
Human necessities

Modified release compositions of a gamma-hydroxybutyric acid derivative

#16 | 2022-02-24 ✅ Patent 11,279,669 granted on 2022-03-22
US20220055982A1
Chemistry; metallurgy

Methods of synthesizing 4-valyloxybutyric acid

#17 | 2022-01-27 ✅ Patent 11,896,573 granted on 2024-02-13
US20220023247A1
Human necessities

Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative

#18 | 2022-01-06 ✅ Patent 11,905,247 granted on 2024-02-20
US20220002246A1
Chemistry; metallurgy

Compounds as neurokinin-1 receptor antagonists and uses thereof

#19 | 2021-12-23 ✅ Patent 11,357,734 granted on 2022-06-14
US20210393537A1
Human necessities

Pharmaceutical granulations of water-soluble active pharmaceutical ingredients

#20 | 2021-12-23 ✅ Patent 11,304,906 granted on 2022-04-19
US20210393529A1
Human necessities

Controlled release granulations of water-soluble active pharmaceutical ingredients

#21 | 2021-06-24 ✅ Patent 11,420,955 granted on 2022-08-23
US20210188808A1
Chemistry; metallurgy

Compounds as neuronal histamine receptor-3 antagonists and uses thereof

#22 | 2021-04-01 ✅ Patent 11,401,249 granted on 2022-08-02
US20210094925A1
Chemistry; metallurgy

Bicyclic heteroaryl derivatives and preparation and uses thereof

#23 | 2021-03-25 ✅ Patent 11,767,313 granted on 2023-09-26
US20210087177A1
Chemistry; metallurgy

Compounds as nuclear transport modulators and uses thereof

#24 | 2021-03-04 ✅ Patent 11,312,703 granted on 2022-04-26
US20210061791A1
Chemistry; metallurgy

Reactive oxygen species scavengers and use for treating diseases

#25 | 2021-02-18 ✅ Patent 11,692,008 granted on 2023-07-04
US20210047367A1
Chemistry; metallurgy

Preparation and uses of reactive oxygen species scavenger derivatives

#26 | 2021-02-04 ✅ Patent 11,440,874 granted on 2022-09-13
US20210032199A1
Chemistry; metallurgy

Ketamine derivatives and compositions thereof

#27 | 2020-07-30 ✅ Patent 11,149,006 granted on 2021-10-19
US20200239416A1
Chemistry; metallurgy

Compounds as neurokinin-1 receptor antagonists and uses thereof

Also check out XWPHARMA LTD.'s (Grand Cayman, Cayman Islands) applicant profile with 31 patent applications submitted.

AssigneeID:

347916 ⎘